Phase 3 clinical trials started in 2015 provide a snapshot of the medical research landscape. In total, 7 such trials were initiated. Leading sponsors include National Cancer Institute (NCI), Bayer, AstraZeneca.
7 Phase 3 clinical trials were started in 2015 according to ClinicalTrials.gov data tracked by ReadTheTrial.
Phase 3 trials are large-scale pivotal studies with 300-3,000+ participants for FDA approval.
Most trials from 2015 have completed enrollment. Visit the recruiting page for current opportunities.